The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.
Feldman
B M
BM
Department of Pediatrics, University of Toronto, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada. brian.feldman@sickkids.ca
Aledort
L
L
Bullinger
M
M
Delaney
F M
FM
Doria
A S
AS
Funk
S
S
Giangrande
P
P
Lundin
B
B
Manco-Johnson
M
M
Miners
A
A
Scriba
P C
PC
Srivastava
A
A
Schramm
W
W
Blanchette
V S
VS
D003362:Cost-Benefit Analysis; D006291:Health Policy; D006467:Hemophilia A / Q000191:economics* / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007348:Insurance, Health; D009656:North America; D006113:United Kingdom